Itamar Medical Ltd.
Endo
PAT
TM
x Device
58
Operation Manual
7.5.1
Framingham Risk Score
Framingham Risk Score estimates the risk of developing hard CHD adverse events
(myocardial infarction or coronary death) over a course of 10 years (Adults Treatment
Panel III, JAMA 2001).
The risk is given in percentages.
The Framingham Risk Score applies only to people without known heart disease or
diabetes.
For more information, visit
http://www.framinghamheartstudy.org/risk/hrdcoronary.html
7.5.2
SCORE
SCORE is the European risk prediction system providing a 10 year risk of fatal CVD.
SCORE is representative of typical European populations, and the risk score system has
been optimized for coronary prevention in European clinical practice.
Risk may be higher than indicated in:
Sedentary or obese subjects, especially those with central obesity.
Those with a strong family history of premature CVD
The socially deprived
Subject with diabetes – risk may be 5 fold higher in women with diabetes and 3
fold higher in men with diabetes compared to those without diabetes.
Those with low HDL cholesterol or high triglycerides.
Asymptomatic subject with evidence of preclinical arthrosclerosis, for example
reduced ankle-brachial index.
The EndoPAT™ device is using the General version of the SCORE, using the low and
high risk countries (and not national versions).
For this use:
European Low Risk:
Belgium, France, Greece, Italy, Luxembourg,
Spain, Switzerland, and Portugal.
European High Risk
All other European Countries
For more information, search SCORE in:
www.escardio.org
7.5.3
Reynolds Risk Score
Reynolds Risk Score is designed to predict the risk of having a future heart attack, stroke,
or other major heart disease in the next 10 years.
The Reynolds Risk Score is a newly developed score that includes information from the
hsCRP blood test (a measure of inflammation) and whether or not either parents had a
